Table 2. Outcome after transplantation .... | American Society of Hematology

Table 2.

Outcome after transplantation

				Lineage chimerism, %								Lansky score, %
Patient no.	Type of transplant	Chimerism at 1 mo, %	Chimerism at last follow-up, % donor	CD3	CD56	CD15	CD19	Chronic GVHD	Before SCT	After SCT	Clinical status	Time from transplantation, mo
1	MUD	100	100	–	–	–	–	No	60	100	CR	33
2	MUD	100	76	81	NT	64	NT	No	70	90	CR	30
3	MMUD	100	100	–	–	–	–	–	70	–	Died of pneumonitis	–
4	MMUD	100	100	–	–	–	–	Yes, skin	70	100	CR	25
5	MUD	100	100	–	–	–	–	Yes, skin	20	100	CR	32
6	MUD	100	100	–	–	–	–	–	40	–	Died from a hemorrhage	–
7	MUD	100	100	–	–	–	–	Yes, skin, gut	90	90	CR	18
8	Haplo	100	84	100	NT	79	56	No	40	90	CR	65
9	Haplo	100	100	–	–	–	–	–	100	–	Died of pneumonitis	–
10	Haplo	100	2	100	0	0	0	No	80	100	CR	73
11	MFD	100	100	–	–	–	–	No	50	100	CR	18
12	MMUD	100	100	–	–	–	–	No	90	100	CR	9

				Lineage chimerism, %								Lansky score, %
Patient no.	Type of transplant	Chimerism at 1 mo, %	Chimerism at last follow-up, % donor	CD3	CD56	CD15	CD19	Chronic GVHD	Before SCT	After SCT	Clinical status	Time from transplantation, mo
1	MUD	100	100	–	–	–	–	No	60	100	CR	33
2	MUD	100	76	81	NT	64	NT	No	70	90	CR	30
3	MMUD	100	100	–	–	–	–	–	70	–	Died of pneumonitis	–
4	MMUD	100	100	–	–	–	–	Yes, skin	70	100	CR	25
5	MUD	100	100	–	–	–	–	Yes, skin	20	100	CR	32
6	MUD	100	100	–	–	–	–	–	40	–	Died from a hemorrhage	–
7	MUD	100	100	–	–	–	–	Yes, skin, gut	90	90	CR	18
8	Haplo	100	84	100	NT	79	56	No	40	90	CR	65
9	Haplo	100	100	–	–	–	–	–	100	–	Died of pneumonitis	–
10	Haplo	100	2	100	0	0	0	No	80	100	CR	73
11	MFD	100	100	–	–	–	–	No	50	100	CR	18
12	MMUD	100	100	–	–	–	–	No	90	100	CR	9

NT indicates not tested; –, not applicable (linear chimerism is not required for patients who are 100% donor, and CGVD and Lansky scores are not provided for patients who have died).